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Abstract
The use of inferior vena cava (IVC) filter for massive pulmonary emboli (PE) with cardiopulmonary instability has not
beenclinically studied.Wepresent a case series of six suchpatientswhoreceived an IVCfilterwith anticoagulationrather
thanthrombolysisbecause of highriskof bleeding.Acutepulmonaryembolectomywas considered, butwasnotpossible
for a varietyof individual clinical situations.These sixhospitalizedpatients prospectively followed during their admission.
Theyweretriagedtothreemedicalintensive careunits (ICUs) andone surgical ICUinthreeuniversity teachinghospitals.
One patient was transferred fromanother institution.All six patients had severe hypoxia and tenuous cardiopulmonary
status. All required high inspiratory oxygen and hemodynamic support; two requiredmechanical ventilation and vaso-
pressors.An IVCfilterwasplacedemergentlyandanticoagulationwasstartedimmediately.All sixpatientshadresolution
of pulmonary thromboemboli (PTE) on anticoagulationwhile the IVC filter prevented further PE. All six patients were
discharged home in their pre-critical illness state.None of the patients suffered complications fromthis therapy and had
excellentresolutionofcardiopulmonarycollapse.The IVCfilterplacementprevented furthermajoremboliceventswhile
the PTE resolved with anticoagulation. An IVC filter should be considered as an adjunct to anticoagulation therapy for
those patientswithmassive PE and cardiopulmonary instability who are notcandidates for thrombolysis, and acute pul-
monaryembolectomyis notreadily available or is of veryhighrisk.r2002 Elsevier Science Ltd.Allrights reserved.
Available online athttp://www.sciencedirect.com
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Autopsy studies have shown that the majority of pul-
monary emboli (PE) originate in the deep veins of the
lower extremities (1). Although anticoagulation therapy
remains the ¢rst line therapy (2), inferior verna cava
(IVC) ¢lters have been proven e¡ective in preventing
acute embolization of large blood clots into the pulmon-
ary circulation (3,4). In fact, IVC ¢lters are placed for
‘‘added protection’’ (5) in some situations.Moser has re-
commended (6,7) the use of IVC ¢lters with compro-
mised pulmonary vascular beds from further PE risk.
Although recommended and routinely used in patientsReceived 24 September 2001, accepted in revised form 28 May 2002
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vestigated for themanagementofmassive PE; in particu-
lar, those with cardiopulmonary instability manifesting
as hypotension, right ventricular dysfunction, or acute
respiratory failure. We report our experience with six
patientswhowouldhave received thrombolysis for mas-
sive pulmonary thromboemboli (PTE), but were at high
risk of bleeding; instead, they received anticoagulation,
cardiopulmonary support, and had an emergent IVC ¢l-
ter placed as an adjunct to therapy.Pulmonary embolect-
omy was considered but was high risk. Their clinical
characteristics are summarized inTable1.
MATERIALSANDMETHODS
Weprospectively followed six patients in three di¡erent
hospitals in four di¡erent intensive care units (ICUs) un-
der a uni¢ed academic pulmonary/critical care division.
INFERIORVENACAVAFILTER ASATREATMENTMODALITY 985Two hospitals were private university teaching hospitals
and onewas a city university hospital; the former had pa-
tients with both private physicians and faculty coverage
while the latter had entirely faculty coverage.Two ICUs
were general medical ICUs, one was an ICU focused on
pulmonary critical care and one was a cardiothoracic
ICU.Onepatientwas transferred from another hospital.
All six patients had documentedmassive PE and cardi-
ovascular compromise. They received immediate antic-
oagulation, oxygen, £uids and hemodynamic support as
needed. All but one had documented deep vein throm-
bosis (DVT) byduplex sonogram.Thrombolysiswas con-
sidered for all six patients but was not given because all
had high risk of bleeding (9) and, catheter embolectomy
was not readily available.Thoracotomy with pulmonary
embolectomy was considered; however, operative risks
and post-operative complications were deemed extre-
mely high. Instead, an emergent IVC ¢lter was placed as
an adjunct to anticoagulation, and cardiopulmonary sup-
portive care.They survived andwere discharged in their
pre-critical illness condition.
RESULTS
Patient1
A 77-year-old obesewomanwith history of breast carci-
noma and total knee replacement presented with acute
onset shortness of breath, and a clear chest ¢lm. Shewas
hypotensive, breathing at 36/min1, and the partial pres-
sure of oxygen in arterialblood (PaO2)was 40Torr while
breathing room air.The oxygen saturation on100% oxy-
gen by facemask was 91%. A ventilation/perfusion (V/Q)
scan was read as high probability for PE. The transeso-
phageal echocardiogram (TEE) showed right ventricular
hyopkinesis, a large right to left intra-cardiac shunt, a
mean pulmonary artery pressure (PAP) of 40mmHg,
and normal left ventricular ejection fraction. Lower ex-
tremity venous duplex scan was positive for DVT. The
patientwas placedonheparin and an emergent IVC ¢lter
was inserted.Thrombolysiswas contraindicatedbecause
she developed hematemesis and the presence of a large
right to left shunt.Oxygen requirements decreased over
the next 3 days. Repeat V/Q scan 5 days later showed
marked improvement of mismatches. Patient was dis-
chargedhome onwarfarin.
Patient 2
A 45-year-old man who had coronary artery bypass
graft (CABG) 10 days earlier developed heparin-induced
thrombocytopenia (HIT) complicated by clot formation
in both lower extremities and the left upper extremity
and PE.Clot burden in the lower extremities was signi¢-
cant while that of the left upper extremity wasminimal.
While receiving hirudin, the patient’s respiratory statusacutely worsened. A spiral chest computed tomography
(CT) showed thrombus in the left pulmonary artery and
right upper posterior pulmonary artery and atrial
thrombus. Mechanical ventilation and vasopressor sup-
port with norepinephrine at 13mg/min was required.
The PaO2 on 100% oxygen with mechanical ventilation
was only 116Torr. An emergent IVC ¢lter was placed.
Thrombolysis was contraindicated because of recent
CABG. The cardiopulmonary status improved over the
next 2 days.The patient was thenweaned from the ven-
tilator and vasopressor support was discontinued. He
was discharged home onwarfarin.
Patient 3
A 55-year-old woman with mental retardation and sei-
zure disorder was admitted from a long-term care facil-
ity with weakness, hypoxia and a clear chest ¢lm.With
mechanical ventilation, the PaO2 was only 84Torr on
100% oxygen with positive end expiratory pressure of
10mmHg. She required vasopressor support with nore-
pinephrine at 13mg/min. A spiral chest CT of the chest
showed large PE occluding the ¢rst segment of the right
main pulmonary artery and the left descending pulmon-
ary artery. The head CT scan showed schizencephally
with hydrocephalus and evidence of old stroke a¡ecting
the left corona and posterior limb. A venous duplex
showed a left common femoral vein DVTat the saphe-
nous^ femoral vein junction. Heparin was started and
an emergent IVC ¢lter was placed. An echocardiogram
showedright heart dilation and failure, a large atrial sep-
tal defect and severe right to left shunt. Anticoagulation
was continued despite the fact that she was having me-
nometrorrhagia requiring blood transfusion.Her oxyge-
nation worsened secondary to multiple pulmonary
infarctions to thepointwheremechanical ventilationbe-
came ine¡ective. An angiogram was performed and re-
combinant tissue plasminogen activator (rt-PA) was
infused directly in the pulmonary artery, 10mg in the
right main and 5mg in the left main pulmonary artery
to recruit non-infarcted alveoli.Thismaneuver improved
oxygenation very slightly but allowed e¡ective mechani-
cal ventilation.Oxygenation gradually improved over the
next few days on anticoagulation and she was weaned
from mechanical ventilation and vasopressor support.
Shewas eventuallydischarged from thehospital and later
diagnosed with endometrial carcinoma of the uterus.
The contraindications to thrombolysis were active
bleeding, central nervous system abnormalities, and a
large right to left intra-cardiac shunt.
Patient 4
An 85-year-oldman presented with shortness of breath
and a clear chest ¢lm. The V/Q scan showed high prob-
TABLE 1. Radiographic and clinical data of patients
Patient V/Q or spiral CT Venous duplex Echo/EKG Hemodynamic status Oxygenation Risk factor Contraindications for
thrombolysis
1 V/QFhigh probabil-
ity for PE
DVT Echo F RV failure,
large intra-atrial com-
munication
Nopressors required Room air ABGF7.41/
33/40/76%. FIO2 100%
on FMFSaturation
91%
Breast CA, obesity,
recentknee surgery
Hematemesis, large
rightto left shunt
EKGFparadoxical
anterior wall ST
changes
2 Spiral CTFPE DVT EchF normal but
done10 days afterintu-
bation
Norepinephrine up to
13 mg/min
MVFFIO2
100%FABGF7.32/
41/116/98%
HIT CABGwithin14 days
EKGFNew RBBB
and Paradoxical
changes
3 Spiral CTFPE DVT EchoFRVdilation and
failure and LVhypokin-
esis, large atrial septal
defect with a large
rightto left shunt
Norepinephrine up to
13 mg/min
MVFPEEP10, FIO2
100%F7.41/25/84/
100%
Endometrial CA CNS malformation,
right to left shunt, me-
nometrorrhagia
EKGFTransient RBBB
4 V/QFhigh probabil-
ity for PE
DVT EchoFPAP 59mm/
Hg,Tricuspid valve re-
gurgitation,LAdilation
MAP decrease by
40mm/Hg
FM FIO2 100%F7.46/
41/54/88%
Agerelatedimmobility Age
EKGFTransient
RBBB
5 Spiral CTFPE DVT ECHOFnormal but
done 4 days afterevent
Systolic BP decreased
by 50mm/Hg
FM FIO2 100%F7.47/
29/51/89%
Immobility secondary
to gunshot
Recent gunshot
wound and chest tube
insertion
EKGFA¢b, RBBB,
and paradoxical
changes
6 V/QFhigh probabil-
ity for PE
Nothrombusin BLE ECHOFright ventri-
cular dysfunction; re-
solved subsequently
on anticoagulation
Blood pressure de-
creased to 90mmHg
systolic
FM FIO2100%FOxy-
gen Saturation 92^
97%
PregnancyF13 weeks Activehemoptysis and
pregnancy
Spiral CTFPE
V/QFventilationperfusion scan; HITFheparin-induced thrombocytopenia;
EchoFechocardiogram; RVFright ventricle;LVFleft ventricle; EKGelectrocardiogram;FMFfacemask; PFOFpatent foramen ovale;DVTFdeep vein thrombosis; CNSFcentral ner-
vous system;MVFmechanical ventilation; PAPFpulmonary artery pressure; FIO2Ffractional inspiratory oxygen; MAPFmean arterial pressure;RBBBFright bundle branch block; LAFleft
atrium; ABGFarterialbloodgas; A¢bFAtrial ¢brillation;BLEFbilaterallowerextremities; BPFbloodpressure.
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INFERIORVENACAVAFILTER ASATREATMENTMODALITY 987ability for pulmonary embolism.Venous duplex was sig-
ni¢cant forDVTon theright lower extremity with anun-
stable clot in the common femoral vein. Anticoagulation
with intravenous heparin was initiated. Few hours later,
his cardiopulmonary status acutely worsened.The PaO2
on 100% oxygen by facemask was 54Torr. Although
there were no absolute contraindications to thromboly-
sis, hewas considered at a high riskof bleeding due to his
age and his long-standing history of hypertension. An
emergent IVC ¢lter was placed. An echocardiogram
showed a PAP of 59mmHg, moderate tricuspid valve
regurgitation, left atrial dilation, and left ventricular
hypertrophy.Over thenext 2 days, thepatient’shemody-
namics stabilized and his respiratory status improved.
Hewas discharged home onwarfarin.
Patient 5
A 65-year-old man was hospitalized for a gunshot
wound. One week into the hospitalization, he suddenly
became short of breath and hypotensive with a systolic
blood pressure of 90mmHg. On 100% oxygen by face-
mask, the PaO2was only 51Torr. A spiral CTof the chest
revealed a clot in the right main pulmonary artery. Ve-
nous duplex showed acute thrombosis of the left and
right common femoral veins. Anticoagulation was in-
itiated and an emergent IVC ¢lter inserted. A recentma-
jor procedure (chest tube) and a gunshot precluded
thrombolysis. His respiratory status improved over the
next 24h and hewas dischargedhome onwarfarin.
PATIENT 6
A 29-year old woman with no signi¢cant prior medical
history presented at 13 weeks of gestation with symp-
toms of shortness of breath.V/Q scan showed no perfu-
sion to the right lung and a small subsegmental perfusion
defect in the left lung.The duplex sonogram of the lower
extremities was negative for DVT.The cardiopulmonary
status remained stable and anticoagulation with heparin
was started. Six days later, oxygenation worsened (on
100% fractional inspiratoryoxygen (FIO2), the oxygen sa-
turation ranged from 92 to 97%) and she developed he-
moptysis secondary to pulmonary infarction.The blood
pressure decreased to 90mmHg systolic and she could
not lie £at.The echocardiogram showed right ventricu-
lar dilatation and elevatedpulmonary pressure. A repeat
V/Q scan showeda newperfusion defect in the left lower
lobe. A spiral CTscan showed distal PE in right lung and
central PE in left lung. An IVC ¢lter was placed emer-
gently because of ongoing PE with cardiopulmonary
compromisewhile on anticoagulation. Arepeat echocar-
diogram and V/Q scan showedresolution of right ventri-
cular strain and resolution of perfusion defects,
respectively. She had a termination of pregnancy. Thecontraindications to thrombolysis were active hemopty-
sis andpregnancy. Shewas dischargedhome onwarfarin.
DISCUSSION
The impact of a PE depends on the extentof reduction in
the total cross-sectional area of the pulmonary vascular
bed and thebaseline cardiac function. Acute PE leads to a
rise in PAP, secondary to mechanical and neurohumoral
e¡ects.Resultinghypoxia contributes to furtherpulmon-
ary artery vasoconstriction and worsening of hemody-
namics. Signi¢cant elevation in PAP pressure usually
occurs when more than 50% of the pulmonary arterial
bed is occluded. As the PAP rises, initially, the right ven-
tricle generates higher pressures and maintains the car-
diac output (CO).Here, as the intra-ventricular pressure
of the thin right ventricle increases, the coronary perfu-
sion decreases:
ðcoronary perfusion ¼ systemicmean arterial pressure
 intra ventricular pressureÞ:
If the embolic burden continues to increase, the left
ventricular pre-load decreases secondary to inter-ven-
tricular dependence, the CO falls resulting in systemic
hypotension, and, eventually the coronary perfusion
further decreases resulting in right ventricular ischemia
and failure (9). In our group of patients, given that all
had tenuous cardiopulmonary status, a large recurrent
PE would have resulted in right heart failure and death.
IVC ¢lter placement prevented further signi¢cant PE
(4), and possibly, the ¢nal fatal event.
IVC ¢lter placement has been recommended with pa-
tients having reduced cardiopulmonary reserve (7). Even
those with a normal baseline cardiopulmonary function,
a massive PE can signi¢cantly compromise cardiopul-
monary status. Patient 6 is an example. Although she
was young with excellent cardiopulmonary function,
the large embolic burden produced cardiopulmonary in-
stability. Available data suggest that most patients have
on the average 6^10 emboli in their pulmonary circula-
tion at the time of presentation (10).These could repre-
sent a large clot that broke up and migrated distally, or
possibly ongoing embolic events.
Goldhaber (9,11) has revolutionized the treatment for
massive PE with thrombolysis. Thrombolysis quickly re-
solves the large PE burden (12) and quickly restores the
cardiopulmonary circulation thus decreasing the chance
of cardiopulmonary collapse as described above. Acutely
relieving thepulmonary arteryclotburden also avoid the
post-IVC ¢lter deaths (5); it is unclear if these deaths are
secondary to recurrent thromboembolic events, or car-
diopulmonary compromise from the initial catastrophic
thromboembolic event. Also, since the only intervention
required is the administration of thrombolytic agents in-
travenously, this therapy iswidely accessible. Thromboly-
TABLE 2
Relative contraindications for thrombolysis
Severe traumawithin 2 months
Any surgical or invasive procedureswithin10 days
Parturitionwithin10 days
Deep biopsieswithin10 days
Hemorrhagic retinopathy
Ophthalmologic surgerywithin 6 weeks
Extended cardiopulmonaryresuscitation
Absolute contraindications for thrombolysis
Active bleeding
Highriskof CNShemorrhage
Priorhemorrhagic CVA
CNStumor
Neurosurgery within 2 months
Arteriovenousmalformation1
Diastolic pressure4110
Bleedingdisorder
TABLE 3 (18,20)
Early complications of IVC ¢lters
Malpositioning
Insertion site thrombosis
Signi¢cantmigration of IVC ¢lter, including into the
right atriumrequiring cardiotomy
Caval thrombosis
Post¢lter pulmonaryembolism
Carotid an femoral arterypuncture
Severe hypotension
Torn internal jugular vein
Groinhematoma
Cavalwallperforation
Filter fracture
Late complications of IVC ¢lters
Duplexevidence of old orchronic DVT
Signs and symptoms of chronic venous insu⁄ciency
Pain
Swelling
Skin changes
Ulceration
Caval thrombosis
988 RESPIRATORYMEDICINEsis remains the ¢rst line therapy for massive pulmonary
embolism.
Potential devastating complications associated with
thrombolysis for PE include bleeding (9) and paradoxical
emboli (13^15). All six patients were at high risk of bleed-
ing from thrombolysis. Patients 1, 3 and 6 had active
bleeding, patients 2 and 5 had recent surgical proce-
dures, while patient 4 was considered high risk of intra-
cranial hemorrhage secondary to age, and long-standing
hypertension.Without contraindications, all six patients
would have received full thrombolysis (rt-PA 100mg in-
travenouslyover 2h). Althoughpatient 3 required a small
dose of rt-PA, the dose receivedwas a fraction of the full
dose of thrombolysis. Althoughbleeding is themostwell
recognized complication (9), paradoxical emboli is well
documented. In the setting of high right heart pressures,
an otherwise closed foramen ovale opens.Thrombolysis
can shower emboli from the venous system that can
cross the intra-atrial connection leading to devastating
complications such as mesenteric ischemia and strokes.
Since15% of the population have a patent foramen ovale,
it is advisable to check for intra-atrial communication
with an echocardiogram. Although extremely e¡ective,
contraindications (Table 2) can preclude the use of
thrombolysis.
Surgical removal of PTE by thoracotomy (16) and
transcutaneous (17) pulmonary embolectomy were
considered, but not possible in these patients.Thoracot-
omy with pulmonary embolectomy was deemed to
be higher risk than the approach we used. Patients
1, 4 and 5 began to improve cardiopulmonary function
within 24^48h. Patient 6 had hemoptysis; potential
pulmonary parenchyma bleeding with the huge dose
of heparin required for cardiopulmonary bypass
would have been devastating. Patient 2 developed a
thrombotic disorder from HIT; although hirudin for
cardiopulmonary bypass was considered, repeat
thoracotomy with possible injury to recent coronary
grafts was deemed to be high risk. Finally, for patient 3,
embolectomy was strongly considered, but she
began to improve cardiopulmonary status after the
angiographic instillation of the small dose of
thrombolytic. Catheter embolectomy was not readily
available.Once perfected and widely available, catheter
embolectomy holds a great potential in the treatment
ofmassive PE.
Theplacementof an IVC ¢lter is generally safe.The re-
ported early and late complications are listed inTable 3.
The rate ofmajor complications reported is as low as 0.3
and 7% (5,18). Late complications include DVT and
chronic venous insu⁄ciency; at 4 years follow-up, these
complications are reported as high as 47 and 37%respec-
tively (18). Because of these chronic complications, life-
long anticoagulation is often recommended (3).
Performing a randomized trial comparing thromboly-
sis with IVC ¢lter placement and anticoagulation for thetreatment of massive PE has been di⁄cult.The greatest
ethical concern is subjecting a young patient to lifelong
anticoagulation or chronic venous stasis complications
with the placement of an IVC ¢lter as opposed to treat-
ment thrombolysis when there are no contraindications.
The hospital course of patients 2, 4 and 6 truly shows
the bene¢ts of IVC ¢lter placement; the three had a sud-
den worsening of cardiopulmonary status from a recur-
rent PE while receiving anticoagulation. IVC ¢lter
placementprevented further embolic eventswith subse-
INFERIORVENACAVAFILTER ASATREATMENTMODALITY 989quent right heart failure, while anticoagulation resolved
the PTE, and oxygen delivery wasmaintainedwith cardi-
opulmonary support.
CONCLUSION
In the subset of patients where thrombolysis is contrain-
dicated, and acute pulmonary embolectomy is of very
high risk or not readily available, emergent IVC ¢lter pla-
cement as an adjunct to anticoagulation therapy with
cardiopulmonary support should be considered as an
option.
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